摘要
目的：了解我院鲍曼不动杆菌的分布特征及其耐药性。探讨治疗对策，为临床合理使用抗生素提供依据。方法：对2008年1月-12月我院送检标本进行细菌培养分离，分离株鉴定使用法国生物梅里埃Vitek ATB系统，药敏试验使用法国生物梅里埃ATB试条。药敏结果根据美国国家临床实验室标准化委员会（National Committee for Clinical Laboratory Standards NCCLS）标准进行判读。结果：全年总计分离出51株鲍曼不动杆菌．主要来源于痰标本（80．39％）。其中以呼吸内科，神经外科，ICU最多，对鲍曼不动杆菌最为敏感的药物是多粘菌素和亚胺培南。结论：鲍曼不动杆菌的耐药率十分严重，应重视防治。
Objective ： To investigate the clinical distribution and resistance of Acinetobacter baumannii in our hospital , so then provide some basis for rational use of antibiotics. Methods ： We cultured and isolated the bacterial specimens submitted for detection in our hospital in Jan. - Dec. 2008. Identification was done by the French bioMerieux Vitek ATB system, while the drag susoeptibility test was by the French bioMerieux ATB strips. The results was judged according to the U.S. National Committee for Chnical Laboratory Standards （NCCLS） standard. Results ： A total of 51 strains Acinetobacter baumannii were separated all the year round, mainly from sputum （80.39%）, and most were in such departments as follows： Department of Respiratory Medicine, Neurosurgery and ICU. The most sensitive drug for Acinetobacter baumarmii was polymyxin and imipenem. Conclusion： The resistant rate of Acinetobacter baumannli is very serious, we should pay more attention.
出处
《医学信息（下旬刊）》
2011年第10期180-181,共2页
Medical information
关键词
鲍曼不动杆菌
耐药性
Acinetobacter baumannii
resistant rate
